OMT-28

· Omeicos Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for OMT-28, covering 2021-09-09 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION) [Phase 2]